Anoshie Ratnayake, MD, MPH
I graduated from Stanford University with Honors in 1997. At Stanford I studied Human Biology, with a focus on Neuroscience and the Mind/Body Relationship, and also pursued a minor in Psychology. While at Stanford, I started to do clinical research and found it was a way to combine my love of the science of medicine and my desire to serve the community. I also learned about acupuncture and Ayurveda, and started to explore how ancient knowledge and the cutting-edge science can be combined to achieve wellness.
After completing my undergraduate training at Stanford, I attended medical school at University of Southern California (USC) Keck School of Medicine where I received an excellent foundation in medicine and continued to do clinical research in Cardiology, Endocrinology, and Allergy/Asthma. Working in a large academic research center and the busy Los Angeles County Medical Center introduced me to a wide array of medical conditions and different scientific approaches to medicine and health.
After completing medical school, I pursued a Master of Public Health (MPH) degree at the Harvard School of Public Health. At Harvard, I focused on global health and population studies. There I continued to better understand the impact of community development, education, and psychosocial factors on health. I also began to better understand the epidemiology of disease as well as the framework for conducting a well-thought out and successful clinical study.
Residency and Fellowship
After completing my MPH at Harvard, I completed my Pediatrics residency at University of Texas Southwestern and UC Irvine. I completed my fellowship in Allergy/Immunology at USC. During this time, I also started to work as a Principal Investigator for clinical trials studies at WCCT Global. I also worked at Kaiser Permanente, where I gained an in depth understanding of how clinical research can impact and help a large healthcare organization
After completing my Allergy/Immunology fellowship, I joined a private practice group and practiced allergy/immunology for two years before returning to clinical trials research.
I served as Medical Director at Lotus Clinical research, where I got successfully managed a wide array of studies in several therapeutic areas and also helped develop new guidelines and processes for clinical trial implementation. In 2012, I returned to WCCT Global, where I managed WCCT Global’s Costa Mesa Unit, overseeing special populations and pediatric studies. I have served as an investigator in pivotal clinical trials for many medications currently on the market, including including Astelin, Omnaris, Advair, Symbicort, and Xolair. Working in the clinical trials industry has given me insight into what makes a medication a good medication and how to best design a successful study to test its worth. I recently led an interdisciplinary team to develop processes to successful implement a novel influenza challenge study, the first privately run flu challenge study in the United States.
Today I provide clinical trials consulting and medical monitoring services, through Stanford Crimson Consulting Group, an organization I founded. I also continue to practice as an allergist in the community. In my free time I enjoy yoga, hiking, baking, and most of all spending time with my husband and two kids.
Brief Bio –
Anoshie Ratnayake, MD, MPH
Dr. Ratnayake graduated from Stanford University with Honors in 1997. She then completed her medical degree at USC Keck School of Medicine. She then pursued a completed a Master of Public Health (MPH) in Global Health and Population Studies at Harvard School of Public Health.
She competed Pediatrics residency at UT Southwestern and UC Irvine and then went on to complete her Allergy/Immunology fellowship at USC.
She has been overseeing clinical trials studies since 2005 and has served as Medical Director and Principal Investigator for phase 1 through phase 4 studies, in a wide array of therapeutic areas. She is board certified in Allergy/Immunology and Pediatrics.
She is founder of the Stanford Crimson Consulting Group.